Silke Brilloff
Dresden, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Cell cycle regulator MYBL2 is a distinct vulnerability in acute myeloid leukemia.
Journal: Cell death discovery
Published: July 30, 2025
A quiescence-like/TGF-β1-specific CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AML.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: November 05, 2024
The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancers.
Journal: Cell death and differentiation
Published: June 07, 2024
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity.
Journal: Cell reports. Medicine
Published: December 19, 2022
ADMA elevation does not exacerbate development of diabetic nephropathy in mice with streptozotocin-induced diabetes mellitus.
Journal: Atherosclerosis. Supplements
Published: December 11, 2019
Kidney and liver are the main organs of expression of a key metabolic enzyme alanine:glyoxylate aminotransferase 2 in humans.
Journal: Atherosclerosis. Supplements
Published: December 11, 2019
Microarray analysis for delineating the gene expression in biopsies of gastrocnemius muscle of patients with chronic critical limb ischaemia compared with non-ischaemic controls.
Journal: VASA. Zeitschrift fur Gefasskrankheiten
Published: March 21, 2018
ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy.
Journal: Atherosclerosis. Supplements
Published: November 04, 2017
Diabetes-linked transcription factor HNF4α regulates metabolism of endogenous methylarginines and β-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2.
Journal: Scientific reports
Published: May 30, 2016
Acetylation of asymmetric and symmetric dimethylarginine: an undercharacterized pathway of metabolism of endogenous methylarginines.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 24, 2015
Last Updated: 09/26/2026